Boardroom Alpha
Boardroom Alpha
TISI · Current Report (Form 8-K) · Filed May 20, 2026

Team Inc — Current Report (Form 8-K)

Form
8-K
Filed
May 20, 2026
Period
May 20, 2026
Ticker
TISI
Accession
0000318833-26-000032
Boardroom Alpha · Filing insights

Shareholders approved Amendment No.1 to increase the Equity Incentive Plan by 250,000 shares.

About Team Inc
Market cap
$110M
1Y TSR
+10.2%
3Y TSR
+29.0%
Board grade
C+
Sector
Industrials
CEO
Gary Hill
Last annual meeting: May 20, 2026 · View full Team Inc profile →
tisi-20260520

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
 
 CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 20, 2026
 
 TEAM, Inc.
(Exact Name of Registrant as Specified in its Charter)
Delaware 001-08604 74-1765729
(State or Other Jurisdiction
of Incorporation)
 (Commission
File Number)
 (IRS Employer
Identification No.)
13131 Dairy Ashford, Suite 600
Sugar Land, Texas 77478
(Address of Principal Executive Offices and Zip Code)
Registrant’s telephone number, including area code: (281) 331-6154
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CF 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.30 par valueTISINew York Stock Exchange

Indicate by check mark whether registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Team, Inc. (the “Company”) held its 2026 Annual Meeting of Shareholders on May 20, 2026 (the “Annual Meeting”). At the Annual Meeting, as described below under Item 5.07, the Company’s shareholders approved Amendment No.1 (the “Plan Amendment”) to the Second Amendment and Restatement of the Team, Inc. 2018 Equity Incentive Plan (the “Equity Incentive Plan”) to increase the number of shares available for issuance under the Equity Incentive Plan by 250,000 shares of common stock, par value $0.30 per share. The Plan Amendment became effective on February 18, 2026, subject to the approval of the Company’s shareholders at the Annual Meeting.

A more complete description of the terms of the Equity Incentive Plan, as amended by the Plan Amendment, can be found in “Proposal Five-Approval of Amendment No. 1 to the Second Amendment and Restatement of the Team, Inc. 2018 Equity Incentive Plan” in the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 28, 2026 (the “Proxy Statement”), which description is incorporated by reference herein. The foregoing description and the description incorporated by reference from the Proxy Statement are qualified in their entireties by reference to (i) the full text of the Equity Incentive Plan incorporated by reference into the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and (ii) the full text of the Plan Amendment, a copy of which is included in the Proxy Statement as Appendix B thereto.

Item 5.07 Submission of Matters to a Vote of Security Holders.

The Company’s shareholders considered five proposals at the Annual Meeting, each of which is described in more detail in the Proxy Statement. At the Annual Meeting, the nominees for election as directors set forth in Proposal One were each re-elected and Proposals Two through Five were each approved. The matters voted upon at the Annual Meeting and the results of the votes were as follows:

Proposal One: Election of Directors

The Company’s shareholders elected three Class I directors to the Board of Directors of the Company to each serve for a three-year term expiring at the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified.

Nominee
Votes For
Withheld
Broker Non-Votes
Anthony R. Horton
2,221,248
83,861
589,860
Evan S. Lederman
2,298,663
6,446
589,860
K. Niclas Ytterdahl
2,297,808
7,301
589,860

Proposal Two: Advisory Vote on Named Executive Officer Compensation

The Company’s shareholders approved, on an advisory basis, named executive officer compensation for fiscal year 2026.

Votes For
Votes Against
Abstentions
Broker Non-Votes
2,246,468
6,521
52,120
589,860

Proposal Three: Ratification of the Appointment of KPMG LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year ending December 31, 2026

The Company’s shareholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

Votes For
Votes Against
Abstentions
Broker Non-Votes
2,867,656
25,835
1,478
0












Proposal Four: Stellex Warrant Shares Issuance Proposal

Pursuant to NYSE Listing Rule 312.03(c), the Company’s shareholders approved the issuance of the shares of common stock, par value $0.30 per share, underlying the Warrants (as defined in the Proxy Statement) in accordance with the terms thereof, including, as applicable, below the Minimum Price to and including the Adjustment Floor (each, as defined in the Proxy Statement).

Votes For
Votes Against
Abstentions
Broker Non-Votes
2,276,017
25,655
3,437
589,860

Proposal Five: Approval of Amendment No.1 to the Second Amendment and Restatement of the Team, Inc. 2018 Equity Incentive Plan

The Company’s shareholders approved Amendment No.1 to the Second Amendment and Restatement of the Team, Inc. 2018 Equity Incentive Plan.

Votes For
Votes Against
Abstentions
Broker Non-Votes
2,290,371
11,662
3,076
589,860

Exhibit number Description
104Cover Page Interactive Data File (embedded within the Inline XBRL document)





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
TEAM, Inc.
By:/s/ James C. Webster
James C. Webster
Executive Vice President, Chief Legal Officer and Secretary
Dated: May 20, 2026



From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Team Inc (TISI)

Reference

Frequently asked questions

When did Team Inc file this 8-K?
Team Inc (TISI) filed this Current Report (Form 8-K) with the SEC on May 20, 2026. The accession number assigned by EDGAR is 0000318833-26-000032.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Shareholders approved Amendment No.1 to increase the Equity Incentive Plan by 250,000 shares. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Team Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Team Inc has filed under CIK 318833, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer